 | | FSE | | 表記: | 3,7,3',4'-TETRAHYDROXYFLAVONE | | 組成式: | C15 H10 O6 | | SMILES: | O=C1c3c(OC(=C1O)c2ccc(O)c(O)c2)cc(O)cc3 | | InChi: | InChI=1S/C15H10O6/c16-8-2-3-9-12(6-8)21-15(14(20)13(9)19)7-1-4-10(17)11(18)5-7/h1-6,16-18,20H | | 別名: | Fisetin | | 定義日: | 2004-10-14 | | 最終更新日: | 2020-05-27 | | 識別子（ID）: | 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one |
|
 | | GB0 | | 表記: | Bacteriochlorophyll g' | | 組成式: | C50 H58 Mg N4 O5 | | SMILES: | C(C=C(/C)CCC=C(CCC=C(/C)C)C)OC(CCC=4C5=C2C1=N7C(C(=C1C(C2C(=O)OC)=O)C)=Cc9c(c(c8C=C3N6=C(C(=C3CC)C)C=C(C=4C)N5[Mg]67n89)C)CC)=O | | InChi: | InChI=1S/C50H59N4O5.Mg/c1-12-34-30(7)37-24-39-32(9)36(20-21-43(55)59-23-22-29(6)19-15-18-28(5)17-14-16-27(3)4)47(53-39)45-46(50(57)58-11)49(56)44-33(10)40(54-48(44)45)26-42-35(13-2)31(8)38(52-42)25-41(34)51-37 | | 定義日: | 2017-08-11 | | 最終更新日: | 2020-05-27 | | 公開日: | 2017-09-06 | | 識別子（ID）: | [methyl 9,14-diethyl-4,8,13,18-tetramethyl-20-oxo-3-{3-oxo-3-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]propyl}-3,4,23,25-tetradehydro-24,26-dihydrophorbine-21-carboxylatato(2-)-kappa~4~N~23~,N~24~,N~25~,N~26~]magnesium |
|
 | | VM1 | | 表記: | 5-(2-thienyl)nicotinic acid | | 組成式: | C10 H7 N O2 S | | SMILES: | O=C(O)c2cncc(c1sccc1)c2 | | InChi: | InChI=1S/C10H7NO2S/c12-10(13)8-4-7(5-11-6-8)9-2-1-3-14-9/h1-6H,(H,12,13) | | 別名: | 5-thiophen-2-ylpyridine-3-carboxylic acid | | 定義日: | 2009-09-18 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | 5-(thiophen-2-yl)pyridine-3-carboxylic acid |
|
 | | URP | | 表記: | N-(AMINOCARBONYL)-BETA-ALANINE | | 組成式: | C4 H8 N2 O3 | | SMILES: | O=C(O)CCNC(=O)N | | InChi: | InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9) | | 別名: | N-CARBAMYL-BETA-ALANINE | | 定義日: | 2006-02-06 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | N-carbamoyl-beta-alanine |
|
 | | 1C6 | | 表記: | 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole | | 組成式: | C17 H19 N3 O2 S | | SMILES: | n2c1ccc(OC)cc1nc2SCc3ncc(c(OC)c3C)C | | InChi: | InChI=1S/C17H19N3O2S/c1-10-8-18-15(11(2)16(10)22-4)9-23-17-19-13-6-5-12(21-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20) | | 別名: | omeprazole | | 定義日: | 2013-04-29 | | 最終更新日: | 2020-05-26 | | 公開日: | 2013-07-10 | | 識別子（ID）: | 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole |
|
 | | WM1 | | 表記: | pyridine-2-carboxamide | | 組成式: | C6 H6 N2 O | | SMILES: | O=C(N)c1ncccc1 | | InChi: | InChI=1S/C6H6N2O/c7-6(9)5-3-1-2-4-8-5/h1-4H,(H2,7,9) | | 別名: | Picolinamide | | 定義日: | 2013-10-16 | | 最終更新日: | 2020-05-26 | | 公開日: | 2015-08-12 | | 識別子（ID）: | pyridine-2-carboxamide |
|
 | | 1F0 | | 表記: | [(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl]{4-[3-(methylsulfonyl)propyl]piperazin-1-yl}methanone | | 組成式: | C38 H48 Cl2 N4 O4 S | | SMILES: | O=C(N1CCN(CCCS(=O)(=O)C)CC1)N4C(=NC(c2ccc(Cl)cc2)(C4(c3ccc(Cl)cc3)C)C)c5ccc(cc5OCC)C(C)(C)C | | InChi: | InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1 | | 別名: | RO5045337 | | 定義日: | 2013-01-10 | | 最終更新日: | 2020-05-26 | | 公開日: | 2013-02-15 | | 識別子（ID）: | [(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl]{4-[3-(methylsulfonyl)propyl]piperazin-1-yl}methanone |
|
 | | YMP | | 表記: | O-(ADENOSINE-5'-O-YL)-N-(L-TYROSYL)PHOSPHORAMIDATE | | 組成式: | C19 H24 N7 O8 P | | SMILES: | O=C(NP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O)C(N)Cc4ccc(O)cc4 | | InChi: | InChI=1S/C19H24N7O8P/c20-11(5-9-1-3-10(27)4-2-9)18(30)25-35(31,32)33-6-12-14(28)15(29)19(34-12)26-8-24-13-16(21)22-7-23-17(13)26/h1-4,7-8,11-12,14-15,19,27-29H,5-6,20H2,(H2,21,22,23)(H2,25,30,31,32)/t11-,12+,14+,15+,19+/m0/s1 | | 別名: | TYROSYL-ADENYLATE ANALOGUE | | 定義日: | 2006-05-02 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | 5'-O-[(S)-hydroxy(L-tyrosylamino)phosphoryl]adenosine |
|
 | | XTS | | 表記: | 9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PURINE-2,6-DIONE | | 組成式: | C10 H12 N4 O6 | | SMILES: | O=C3Nc1c(ncn1C2OC(C(O)C2O)CO)C(=O)N3 | | InChi: | InChI=1S/C10H12N4O6/c15-1-3-5(16)6(17)9(20-3)14-2-11-4-7(14)12-10(19)13-8(4)18/h2-3,5-6,9,15-17H,1H2,(H2,12,13,18,19)/t3-,5-,6-,9+/m1/s1 | | 別名: | XANTHOSINE | | 定義日: | 2007-03-02 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | xanthosine |
|
 | | 1J1 | | 表記: | N~6~-[(2R)-3,4-dihydro-2H-pyrrol-2-ylcarbonyl]-L-lysine | | 組成式: | C11 H19 N3 O3 | | SMILES: | O=C(NCCCCC(C(=O)O)N)C1N=CCC1 | | InChi: | InChI=1S/C11H19N3O3/c12-8(11(16)17)4-1-2-6-14-10(15)9-5-3-7-13-9/h7-9H,1-6,12H2,(H,14,15)(H,16,17)/t8-,9+/m0/s1 | | 別名: | pyrroline-carboxy-lysine | | 定義日: | 2013-02-11 | | 最終更新日: | 2020-05-26 | | 公開日: | 2013-06-12 | | 識別子（ID）: | N~6~-[(2R)-3,4-dihydro-2H-pyrrol-2-ylcarbonyl]-L-lysine |
|
 | | VJK | | 表記: | (2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-[2,2,2-tris(fluoranyl)ethyl]butanamide | | 組成式: | C18 H19 F3 N6 O | | SMILES: | C(C(Nc1ccnc(n1)c2cnc3c2cccn3)(C)C(NCC(F)(F)F)=O)C | | InChi: | InChI=1S/C18H19F3N6O/c1-3-17(2,16(28)25-10-18(19,20)21)27-13-6-8-23-15(26-13)12-9-24-14-11(12)5-4-7-22-14/h4-9H,3,10H2,1-2H3,(H,22,24)(H,25,28)(H,23,26,27)/t17-/m1/s1 | | 別名: | Decernotinib | | 定義日: | 2015-03-20 | | 最終更新日: | 2020-05-26 | | 公開日: | 2015-08-12 | | 識別子（ID）: | N~2~-[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]-N-(2,2,2-trifluoroethyl)-D-isovalinamide |
|
 | | 0PY | | 表記: | pyridine | | 組成式: | C5 H5 N | | SMILES: | n1ccccc1 | | InChi: | InChI=1S/C5H5N/c1-2-4-6-5-3-1/h1-5H | | 別名: | Azabenzene | | 定義日: | 2009-04-09 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | pyridine |
|
 | | 89F | | 表記: | 1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine | | 組成式: | C20 H24 N2 S2 | | SMILES: | CSc1ccc2Sc3ccccc3C[CH](N4CCN(C)CC4)c2c1 | | InChi: | InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3/t18-/m0/s1 | | 別名: | Methiothepin | | 定義日: | 2017-05-19 | | 最終更新日: | 2020-05-26 | | 公開日: | 2018-02-07 | | 識別子（ID）: | 1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine |
|
 | | 8CB | | 表記: | (1'R,2'R)-4,5'-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol | | 組成式: | C17 H22 O2 | | SMILES: | Oc2c(C1C(CCC(=C1)C)/C(C)=C)c(O)cc(c2)C | | InChi: | InChI=1S/C17H22O2/c1-10(2)13-6-5-11(3)7-14(13)17-15(18)8-12(4)9-16(17)19/h7-9,13-14,18-19H,1,5-6H2,2-4H3/t13-,14+/m0/s1 | | 別名: | cannabidiorcin | | 定義日: | 2018-07-26 | | 最終更新日: | 2020-05-26 | | 公開日: | 2019-02-13 | | 識別子（ID）: | (1'R,2'R)-4,5'-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol |
|
 | | 1PS | | 表記: | 3-PYRIDINIUM-1-YLPROPANE-1-SULFONATE | | 組成式: | C8 H11 N O3 S | | SMILES: | [O-]S(=O)(=O)CCC[n+]1ccccc1 | | InChi: | InChI=1S/C8H11NO3S/c10-13(11,12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2 | | 別名: | 1-(3-SULFOPROPYL) PYRIDINIUM | | 定義日: | 2003-11-14 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | 3-pyridinium-1-ylpropane-1-sulfonate |
|
 | | 1SY | | 表記: | cGAMP | | 組成式: | C20 H24 N10 O13 P2 | | SMILES: | O=C7N=C(N)Nc1c7ncn1C5OC6COP(=O)(O)OC4C(OC(n2c3ncnc(N)c3nc2)C4O)COP(=O)(OC5C6O)O | | InChi: | InChI=1S/C20H24N10O13P2/c21-14-8-15(24-3-23-14)29(4-25-8)18-11(32)12-7(41-18)2-39-45(36,37)43-13-10(31)6(1-38-44(34,35)42-12)40-19(13)30-5-26-9-16(30)27-20(22)28-17(9)33/h3-7,10-13,18-19,31-32H,1-2H2,(H,34,35)(H,36,37)(H2,21,23,24)(H3,22,27,28,33)/t6-,7-,10-,11-,12-,13-,18-,19-/m1/s1 | | 別名: | 2',3' cGAMP | | 定義日: | 2013-05-24 | | 最終更新日: | 2020-05-26 | | 公開日: | 2013-06-12 | | 識別子（ID）: | 2-amino-9-[(2R,5R,7R,8R,10S,12aR,14R,15R,15aS,16R)-14-(6-amino-9H-purin-9-yl)-2,10,15,16-tetrahydroxy-2,10-dioxidooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecin-7-yl]-3,9-dihydro-6H-purin-6-one |
|
 | | 1WE | | 表記: | (2S)-1-phenylpropan-2-amine | | 組成式: | C9 H13 N | | SMILES: | NC(Cc1ccccc1)C | | InChi: | InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1 | | 別名: | Dextroamphetamine | | 定義日: | 2013-07-05 | | 最終更新日: | 2020-05-26 | | 公開日: | 2013-12-11 | | 識別子（ID）: | (2S)-1-phenylpropan-2-amine |
|
 | | 2Y5 | | 表記: | (2R)-1-{[(R)-hydroxy{[(1R,2R,3R,4R,5S,6R)-2,3,5,6-tetrahydroxy-4-(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | | 組成式: | C47 H84 O16 P2 | | SMILES: | O=C(OCC(OC(=O)CCCC=C/CC=C/CC=C/CC=C/CCCCC)COP(=O)(O)OC1C(O)C(O)C(OP(=O)(O)O)C(O)C1O)CCCCCCCCCCCCCCCCC | | InChi: | InChI=1S/C47H84O16P2/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(49)61-39(37-59-40(48)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2)38-60-65(57,58)63-47-44(52)42(50)46(43(51)45(47)53)62-64(54,55)56/h11,13,17,19,22,24,28,30,39,42-47,50-53H,3-10,12,14-16,18,20-21,23,25-27,29,31-38H2,1-2H3,(H,57,58)(H2,54,55,56)/b13-11-,19-17-,24-22-,30-28-/t39-,42-,43+,44-,45-,46+,47+/m1/s1 | | 別名: | Phosphatidylinositol-4-phosphate | | 定義日: | 2014-05-12 | | 最終更新日: | 2020-05-26 | | 公開日: | 2015-07-29 | | 識別子（ID）: | (2R)-1-{[(R)-hydroxy{[(1R,2R,3R,4R,5S,6R)-2,3,5,6-tetrahydroxy-4-(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate |
|
 | | 794 | | 表記: | 2-[(CARBOXYCARBONYL)(1-NAPHTHYL)AMINO]BENZOIC ACID | | 組成式: | C19 H13 N O5 | | SMILES: | O=C(N(c2c1ccccc1ccc2)c3ccccc3C(=O)O)C(=O)O | | InChi: | InChI=1S/C19H13NO5/c21-17(19(24)25)20(16-10-4-3-9-14(16)18(22)23)15-11-5-7-12-6-1-2-8-13(12)15/h1-11H,(H,22,23)(H,24,25) | | 別名: | COMPOUND 5 | | 定義日: | 2003-01-30 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | 2-[(carboxycarbonyl)(naphthalen-1-yl)amino]benzoic acid |
|
 | | 630 | | 表記: | 1-{(3R,4R)-3-[({5-chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}propan-1-one | | 組成式: | C19 H24 Cl N7 O3 | | SMILES: | N(c1cn(nc1)C)c3nc(OCC2C(CN(C(CC)=O)C2)OC)c4c(n3)ncc4Cl | | InChi: | InChI=1S/C19H24ClN7O3/c1-4-15(28)27-7-11(14(9-27)29-3)10-30-18-16-13(20)6-21-17(16)24-19(25-18)23-12-5-22-26(2)8-12/h5-6,8,11,14H,4,7,9-10H2,1-3H3,(H2,21,23,24,25)/t11-,14+/m1/s1 | | 別名: | Bound form of PF-06459988 | | 定義日: | 2016-01-18 | | 最終更新日: | 2020-05-26 | | 公開日: | 2016-01-27 | | 識別子（ID）: | 1-{(3R,4R)-3-[({5-chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}propan-1-one |
|
 | | 69Q | | 表記: | 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol | | 組成式: | C19 H17 F6 N7 O | | SMILES: | c3(cccc(c1nc(NCC(O)(C)C)nc(n1)Nc2cc(ncc2)C(F)(F)F)n3)C(F)(F)F | | InChi: | InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32) | | 別名: | Enasidenib | | 定義日: | 2016-02-22 | | 最終更新日: | 2020-05-26 | | 公開日: | 2017-03-08 | | 識別子（ID）: | 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol |
|
 | | 5BX | | 表記: | (5S)-5-[(1R)-1-(1H-indol-3-yl)ethyl]-2-(methylamino)-1,3-oxazol-4(5H)-one | | 組成式: | C14 H15 N3 O2 | | SMILES: | CNC=1OC(C(N=1)=O)C(c2c3c(nc2)cccc3)C | | InChi: | InChI=1S/C14H15N3O2/c1-8(12-13(18)17-14(15-2)19-12)10-7-16-11-6-4-3-5-9(10)11/h3-8,12,16H,1-2H3,(H,15,17,18)/t8-,12+/m1/s1 | | 別名: | Indolemycin | | 定義日: | 2015-09-03 | | 最終更新日: | 2020-05-26 | | 公開日: | 2015-11-18 | | 識別子（ID）: | (5S)-5-[(1R)-1-(1H-indol-3-yl)ethyl]-2-(methylamino)-1,3-oxazol-4(5H)-one |
|
 | | 70E | | 表記: | 6-O-[(2R,3R)-3-hydroxy-2-tetradecyldocosanoyl]-alpha-L-idopyranose | | 組成式: | C42 H82 O8 | | SMILES: | C(OCC1C(C(C(C(O)O1)O)O)O)(C(C(O)CCCCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCC)=O | | InChi: | InChI=1S/C42H82O8/c1-3-5-7-9-11-13-15-17-18-19-20-21-23-25-27-29-31-33-36(43)35(32-30-28-26-24-22-16-14-12-10-8-6-4-2)41(47)49-34-37-38(44)39(45)40(46)42(48)50-37/h35-40,42-46,48H,3-34H2,1-2H3/t35-,36-,37+,38-,39+,40-,42-/m1/s1 | | 別名: | C36 GLUCOSE MONOMYCOLATE | | 定義日: | 2016-08-04 | | 最終更新日: | 2020-05-26 | | 公開日: | 2016-11-16 | | 識別子（ID）: | 6-O-[(2R,3R)-3-hydroxy-2-tetradecyldocosanoyl]-alpha-L-idopyranose |
|
 | | 72B | | 表記: | [(amino-kappaN)methanethiolato](3-fluoro-9-methoxypyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H,12H)-dionato-kappa~2~N,N')(N-methyl-1,4,7-trithiecan-9-amine-kappa~3~S~1~,S~4~,S~7~)ruthenium | | 組成式: | C27 H29 F N5 O3 Ru S4 | | SMILES: | O=C1c3c(C(=O)N1)c2cc(F)cn9c2c5c3c4cc(OC)ccc4n5[Ru]798(NCS)S6CCS8CC(NC)CS7CC6 | | InChi: | InChI=1S/C18H10FN3O3.C8H17NS3.CH4NS.Ru/c1-25-8-2-3-11-9(5-8)12-14-13(17(23)22-18(14)24)10-4-7(19)6-20-15(10)16(12)21-11 | | 別名: | (3-fluoro-9-methoxypyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H,12H)-dionato)(N-methyl-1,4,7-trithiacyclodecan-9-amine)ruthenium(II)-isothiocyanate | | 定義日: | 2014-12-21 | | 最終更新日: | 2020-05-26 | | 公開日: | 2015-01-21 | | 識別子（ID）: | [(amino-kappaN)methanethiolato](3-fluoro-9-methoxypyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H,12H)-dionato-kappa~2~N,N')(N-methyl-1,4,7-trithiecan-9-amine-kappa~3~S~1~,S~4~,S~7~)ruthenium |
|
 | | AB1 | | 表記: | N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE | | 組成式: | C37 H48 N4 O5 | | SMILES: | O=C(NC(Cc1ccccc1)C(O)CC(NC(=O)C(N2C(=O)NCCC2)C(C)C)Cc3ccccc3)COc4c(cccc4C)C | | InChi: | InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 | | 別名: | ABT-378 | | 定義日: | 2002-09-24 | | 最終更新日: | 2020-05-26 | | 識別子（ID）: | (2S)-N-[(1S,3S,4S)-1-benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide |
|
